Interaction between isoprenaline and aminophylline in asthma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Armitage, P. (1971). Statistical Methods in Medical Research, pp. 226-239. Blackwell, Oxford.
Ball, J. H., Kaminsky, N. I., Hardman, J. G., Broadus, A. E., Sutherland, E. W., and Liddle, G. W. (1972). Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man. Journal of Clinical Investigation, 51, 2124-2129.
Broadus, A. E., Hardman, J. G., Kaminsky, N. I., Ball, J. H., Sutherland, E. W., and Liddle, G. W. (1971). Extracellular cyclic nucleotides. Annals of the New York Academy of Sciences, 185, 50-66.
Butcher, R. W., and Sutherland, E. W. (1962). Adenosine 3'5' phosphate in biological materials. I. Purification and properties of cyclic 3'5' nucleotide phosphodiesterase and use of this enzyme to characterise adenosine 3'5' phosphate in human urine. Journal of Biological Chemistry, 237, 12441250.
Cohen, B. M., and Elizabeth, N. J. (1974). Sympathomimetic/xanthine broncholysis in obstructive ventilatory disorders. International Journal of Clinical Pharmacology, 9, 6-15.
Ellul-Micallef, R., and Fenech, F. F. (1975). Effect of intravenous prednisolone in asthmatics with diminished adrenergic responsiveness. Lancet, 2, 1269-1271.
Gilman, A. G. (1970). A protein binding assay for adenosine 3'5'-cyclic monophosphate. Proceedings of the National Academy of Sciences, 67, 305-312.
Hume, K. M., and Rhys Jones, E. (1961). The response to bronchodilators in intrinsic asthma. Quarterly Journal of Medicine, 30, 189-199.
Kaliner, M. A., Orange, R. P., Koopman, W. J., Austen, K. F., and Laraia P. J. (1971). Cyclic adenosine 3'5'-monophosphate in human lung. Biochimica et Biophysica Acta, 252, 160-164.
Karlberg, B. E., Henriksson, K. G., and Andersson, R. G. G. (1974). Cyclic adenosine 3'5'-monophosphate concentration in plasma, adipose tissue and skeletal muscle in normal subjects and in patients with hyperand hypothyroidism. Journal of Clinical Endocrinology and Metabolism, 39, 96-
Leading article (1970). Cyclic AMP: The second messenger. Lancet, 2, 1119. Lichtenstein, L. M.. and Margolis, S. (1968). Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science, 161, 902-903.
McFadden, J. R., Jr., and Linden, D. A. (1972). A reduction in maximum mid-expiratory flow rateA spirographic manifestation of small airway disease. A merican Journal of Medicine, 52, 725737.
Palmer, K. N. V., Gaddie, J., and Skinner, C. (1974). Alpha-adrenoceptor-blocking drugs in asthma (letter). British Medical Journal, 4, 409.
Patel, K. R., and Kerr, J. W. (1975). Alpha-receptorblocking drugs in bronchial asthma (letter). Lancet, 1, 348-349.
Pearson, R. M., Bending, M. R., Bulpitt, C. J., George, C. F., Hole, D. R., Williams, F. M., and Breckenridge, A. M. (1976). Trial of combination of guanethidine and exprenolol in hypertension. British Medical Journal, 1, 933-936.
Pihlajamaki, K., Kanto, J., and Iisalo, E. (1972). Human and animal studies on the interactions between glyphylline and isoprenaline. Journal of Asthma Research, 2, 255-261.
Rall, T. W., and West, T. C. (1953). The potentiation of cardiac inotropic responses to norepinephrine by theophylline. Journal of Pharmacology and Experimental Therapeutics, 139, 269-274.
Robinson, B. F., Epstein, S. E., Beiser, G. D., and Braunwald, E. (1966). Control of heart rate by the autonomic nervous system. Circulation Research, 19, 400-411.
Robinson, S., Pearcy, M., Brueckman, F. R., Nicholas, J. R., and Miller, D. I. (1953). Effects of atropine on heart rate and oxygen intake in working man. Journal of Applied Physiology, 5, 508-512.
Robison, G. A., Sutherland, E. W., and Butcher, R. W. (1971). Cyclic AMP, pp. 146-231. Academic Press, London and New York. Veldstra, H. (1956). Synergism and potentiation. Pharmacological Reviews, 8, 339-387.